Share

Laurence Katznelson, MD, Named Vice Dean, Medical Education at Cedars-Sinai

Laurence Katznelson Laurence Katznelson, MD, a national leader in graduate medical education and a distinguished physician-scientist in endocrinology and metabolism, will join Cedars-Sinai as vice dean of Medical Education on May 1. Katznelson will oversee Cedars-Sinai’s Graduate Medical Education, Continuing Medical Education, the Women’s Guild Simulation Center for Advanced Clinical Skills, the Chuck Lorre School of Allied Health, and...
Share

Endocrine Society Celebrates Special Diabetes Program Extension

The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several...
Share

Pharma Fridays – March 8, 2024

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Sandoz Receives FDA Approval for Denosumab Biosimilars On March 5, Sandoz announced that the U.S. Food and Drug Administration (FDA) approved Wyost® (denosumab-bbdz) and Jubbonti® (denosumab-bbdz), the first and only FDA-approved denosumab biosimilars, to treat all indications of the reference medicines.  Keren Haruvi,...
Share

Carol Lange, PhD, Elected 2025-2026 Endocrine Society President

lange-carolphoto453x478 Endocrine Society members elected Carol Lange, PhD, of the University of Minnesota in Minneapolis, Minn., as its 2025-2026 president. She will serve as president-elect for a year beginning in June 2024 before becoming President in June 2025. A professor of medicine and molecular pharmacology and therapeutics, Lange also holds the Tickle Family Land Grant Endowed...
Share

Pharma Fridays – March 1, 2024

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Exact Sciences Launches Riskguard™ Hereditary Cancer Test in the U.S. On February 27, Exact Sciences Corp., announced the launch of the Riskguard™ hereditary cancer test in the United States. The Riskguard test provides an individualized patient report that includes gene specific...
Share

An Ode to Endocrine Society Members Around the World

Mark Headshot As I’ve often said in this column many times over the past decade, the biggest asset that Endocrine News possesses is you, the members of the Endocrine Society. It is an undeniable pleasure to have such a knowledgeable source of information at our fingertips and not only does it make my job easier, but it...
Share

Endocrine Society Supports Federal Legislation Protecting IVF Access

The Endocrine Society is calling for members of Congress to support federal legislation protecting access to in vitro fertilization (IVF). The Access to Family Building Act (S.3612/H.R.7056), proposed by Sens. Tammy Duckworth (D-IL), Patty Murray (D-WA), and Rep. Susan Wild (D-PA), would ensure people can access safe, effective IVF and other assisted reproductive technologies to...